| Company/Division name | FUJIFILM Diosynth Biotechnologies, Texas, (FDB) |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2020 |
| Year reshoring implemented or to be implemented: | 2021 |
| Domestically, the work will be done: | In-house |
| Capital investment ($): | 265 |
| Country(ies) from which reshored: | Japan |
| City reshored to: | College Station |
| State(s) reshored to: | TX |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Covid-19 vaccine candidate NVX-CoV2373 |
| What non-domestic negative factors made offshoring less attractive? | Loss of control |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Covid-19 |
| Government Incentive dollar amount: | $265 million |
